Lazard Asset Management
BLFS icon

Lazard Asset Management’s BioLife Solutions BLFS Stock Holding History

Lazard Asset Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,457
Closed -$44K – 2304
2022
Q4 		$44K Hold
2,457
– – ﹤0.01% 1880
2022
Q3 		$55K Buy
+2,457
New +$52.6K ﹤0.01% 1755
2022
Q2 		– Sell
-2,019
Closed -$45K – 2385
2022
Q1 		$45K Buy
+2,019
New +$53.2K ﹤0.01% 1784
2019
Q4 		– Sell
-756
Closed -$12K – 1534
2019
Q3 		$12K Buy
+756
New +$14.2K ﹤0.01% 1250

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Lazard Asset Management's BLFS Position: Q1 2023 in Review

Lazard Asset Management sold out of BioLife Solutions (BLFS) in Q1 2023, closing a stake of 2,457 shares — an estimated $44K sold.

Lazard Asset Management first reported a position in BLFS in Q3 2019 and held it in 4 quarters. The position peaked at $55K in Q3 2022. 169 funds tracked by Wall St. Rank hold BLFS as of Q1 2023.

  • Lazard Asset Management reported no remaining BioLife Solutions position as of Q1 2023 after selling out during the quarter.
  • Lazard Asset Management sold 2,457 BioLife Solutions shares in Q1 2023, an estimated $44K.
  • Lazard Asset Management first reported a position in BioLife Solutions in Q3 2019 and held it in 4 quarters.
  • Lazard Asset Management's BioLife Solutions position peaked at $55K in Q3 2022.
  • 169 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2023.

Based on Lazard Asset Management's 13F filing for Q1 2023, filed 15 May 2023.